Correlation Between Fate Therapeutics and FibroBiologics, Common
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and FibroBiologics, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and FibroBiologics, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and FibroBiologics, Common Stock, you can compare the effects of market volatilities on Fate Therapeutics and FibroBiologics, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of FibroBiologics, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and FibroBiologics, Common.
Diversification Opportunities for Fate Therapeutics and FibroBiologics, Common
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Fate and FibroBiologics, is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and FibroBiologics, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroBiologics, Common and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with FibroBiologics, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroBiologics, Common has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and FibroBiologics, Common go up and down completely randomly.
Pair Corralation between Fate Therapeutics and FibroBiologics, Common
Given the investment horizon of 90 days Fate Therapeutics is expected to generate 0.48 times more return on investment than FibroBiologics, Common. However, Fate Therapeutics is 2.09 times less risky than FibroBiologics, Common. It trades about 0.0 of its potential returns per unit of risk. FibroBiologics, Common Stock is currently generating about -0.03 per unit of risk. If you would invest 253.00 in Fate Therapeutics on September 23, 2024 and sell it today you would lose (85.00) from holding Fate Therapeutics or give up 33.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 84.07% |
| Values | Daily Returns |
Fate Therapeutics vs. FibroBiologics, Common Stock
Performance |
| Timeline |
| Fate Therapeutics |
| FibroBiologics, Common |
Fate Therapeutics and FibroBiologics, Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fate Therapeutics and FibroBiologics, Common
The main advantage of trading using opposite Fate Therapeutics and FibroBiologics, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, FibroBiologics, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroBiologics, Common will offset losses from the drop in FibroBiologics, Common's long position.| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
| FibroBiologics, Common vs. Fate Therapeutics | FibroBiologics, Common vs. Sana Biotechnology | FibroBiologics, Common vs. Caribou Biosciences | FibroBiologics, Common vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |